Adaptive Biotechnologies Corp (NASDAQ: ADPT) kicked off on Tuesday, remained unchanged from the previous trading day, before settling in for the closing price of $8.42. Over the past 52 weeks, ADPT has traded in a range of $2.28-$8.95.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 22.29% over the past five years. While this was happening, its average annual earnings per share was recorded 13.78%. With a float of $142.73 million, this company’s outstanding shares have now reached $147.77 million.
Let’s look at the performance matrix of the company that is accounted for 709 employees. In terms of profitability, gross margin is 53.84%, operating margin of -93.9%, and the pretax margin is -110.17%.
Adaptive Biotechnologies Corp (ADPT) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Adaptive Biotechnologies Corp is 3.28%, while institutional ownership is 97.87%. The most recent insider transaction that took place on Feb 19 ’25, was worth 1,574,237. In this transaction CEO and Chairman of this company sold 186,080 shares at a rate of $8.46, taking the stock ownership to the 2,576,701 shares. Before that another transaction happened on Feb 20 ’25, when Company’s CEO and Chairman sold 99,107 for $8.44, making the entire transaction worth $836,463. This insider now owns 2,576,701 shares in total.
Adaptive Biotechnologies Corp (ADPT) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.25 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 13.78% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 26.66% during the next five years compared to -1.51% drop over the previous five years of trading.
Adaptive Biotechnologies Corp (NASDAQ: ADPT) Trading Performance Indicators
Take a look at Adaptive Biotechnologies Corp’s (ADPT) current performance indicators. Last quarter, stock had a quick ratio of 2.81. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 6.94.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.08, a number that is poised to hit -0.29 in the next quarter and is forecasted to reach -0.71 in one year’s time.
Technical Analysis of Adaptive Biotechnologies Corp (ADPT)
Adaptive Biotechnologies Corp (NASDAQ: ADPT) saw its 5-day average volume 1.7 million, a positive change from its year-to-date volume of 1.61 million. As of the previous 9 days, the stock’s Stochastic %D was 70.71%. Additionally, its Average True Range was 0.61.
During the past 100 days, Adaptive Biotechnologies Corp’s (ADPT) raw stochastic average was set at 88.68%, which indicates a significant increase from 73.23% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 66.06% in the past 14 days, which was lower than the 81.40% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $7.23, while its 200-day Moving Average is $5.15. Nevertheless, the first resistance level for the watch stands at $8.65 in the near term. At $8.89, the stock is likely to face the second major resistance level. The third major resistance level sits at $9.25. If the price goes on to break the first support level at $8.05, it is likely to go to the next support level at $7.68. Assuming the price breaks the second support level, the third support level stands at $7.45.
Adaptive Biotechnologies Corp (NASDAQ: ADPT) Key Stats
The company with the Market Capitalisation of 1.24 billion has total of 147,579K Shares Outstanding. Its annual sales at the moment are 178,960 K in contrast with the sum of -159,490 K annual income. Company’s last quarter sales were recorded 47,460 K and last quarter income was -33,690 K.
